Adoption of Immune Checkpoint Inhibitors of PD-1 and Comparison of Patient Ages in Clinical Practice vs Trials

Leggi l'articolo originale


This cohort study assesses the speed with which inhibitors of programmed cell death 1 protein reached eligible patients in practice and compares the ages of patients treated in clinical practice with the ages of those treated in pivotal clinical trials.

Lascia un commento